NeutriSci International Inc. provided a further update regarding its entry into the promising Japanese CBD market. Japanese Health Ministry has now approved the NeutriSci licenced product for immediate sale and distribution into Japan. NeutriSci's IP, technology and ingredients were used to create this new broad-spectrum CBD product line introduced by Tabletz LLC. The Tabletz LLC. product mix will initially be comprised of 3 flavours of its quick dissolving sublingual CBD tablets.